Antenatal treatment of fetal alloimmune thrombocytopenia: A current perspective

Haematologica

Volumn 95, Issue 11, 2010, Pages 1807-1811

  Vinograd, Cheryl A ^a   Bussel, James B ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; PREDNISOLONE; PREDNISONE; STEROID; UNCLASSIFIED DRUG; VEINOGLOBULIN I;

ANEMIA; BLOOD GROUP ABO INCOMPATIBILITY; BRAIN HEMORRHAGE; DISEASE MARKER; DISEASE SEVERITY; DRUG EFFICACY; DRUG TREATMENT FAILURE; EDITORIAL; FETUS; FETUS BLOOD SAMPLING; HLA SYSTEM; HUMAN; INVASIVE PROCEDURE; MONOTHERAPY; NEONATAL ALLOIMMUNE THROMBOCYTOPENIA; NON INVASIVE PROCEDURE; PRENATAL CARE; RASH; RECURRENT DISEASE; RISK ASSESSMENT; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; TREATMENT INDICATION; TREATMENT RESPONSE;

ADULT; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; INFUSIONS, INTRAVENOUS; PLATELET COUNT; PREGNANCY; RETROSPECTIVE STUDIES; THROMBOCYTOPENIA, NEONATAL ALLOIMMUNE;

EID: 78149268239     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2010.030148     Document Type: Editorial

References (28)

1. Schulman NR, Marder VJ, Hiller MC, Collier EM. Platelet and leucocyte isoantigens and their antibodies. Prog Haematol. 1964;4:222-304.
2. Bussel JB, Zacharoulis S, Kramer K, McFarland JG, Pauliny J, Kaplan C. Clinical and diagnostic comparison of neonatal alloimmune thrombocytopenia to non-immune cases of thrombocytopenia. Pediatr Blood Cancer. 2005;45(2):176-83.
3. Herman JH, Jumbelic MI, Ancona RJ, Kickler TS. In utero cerebral hemorrhage in alloimmune thrombocytopenia. Am J Pediatr Hematol Oncol. 1986;8(4):312-7.
4. Bussel JB, Berkowitz RL, McFarland JG, Lynch L, Chitkara U. Antenatal treatment of neonatal alloimmune thrombocytopenia. New Engl J Med. 1988;319(21):1374-8.
5. Rayment R, Brunskill SJ, Stanworth S, Soothill PW, Roberts DJ, Murphy MF. Antenatal interventions for fetomaternal alloimmune thrombocytopenia. Cochrane Database Syst Rev. 2005;(1): CD004226.
6. Lynch L, Bussel JB, McFarland JG, Chitkara U, Berkowitz RL. Antenatal treatment of alloimmune thrombocytopenia. Obstet Gynecol. 1992;80(1):67-71.
7. Bussel JB, Berkowitz RL, Lynch L, Lesser ML, Paidas MJ, Huang CL, et al. Antenatal management of alloimmune thrombocytopenia with intravenous gamma-globulin. Am J Obstet Gynecol. 1996;174(5): 1414-23.
8. Dawkins B, Minchinton RM. Fetomaternal alloimmune thrombocytopenia treated with intragam. Med J Aust. 1999;170(9):451-2.
9. Mackenzie F, Brennand J, Peterkin M, Cameron A. Management of fetal alloimmune thrombocytopenia-a less invasive option? J Obstet Gynaecol. 1999;19(2):119-21.
10. Silver RM, Porter TF, Branch DW, Esplin MS, Scott JR. Neonatal alloimmune thrombocytopenia: antenatal management. Am J Obstet Gynecol. 2000;182(5):1233-8.
11. Birchall JE, Murphy MF, Kaplan C, Kroll H. European collaborative study of the antenatal management of feto-maternal alloimmune thrombocytopenia. Br J Haematol. 2003;122(2):275-88.
12. Berkowitz RL, Kolb EA, McFarland JG, Wissert M, Primani A, Lesser M, et al. Parallel randomized trials for fetal alloimmune thrombocytopenia. Obstet Gynecol. 2006;107(1):91-6.
13. Yinon Y, Spira M, Solomon O, Weisz B, Chayen B, Schiff E, et al. Antenatal noninvasive treatment of patients at risk for alloimmune thrombocytopenia without a history of intracranial hemorrhage. Am J Obstet Gynecol. 2006;195(4):1153-7.
14. Berkowitz RL, Lesser ML, McFarland JG, Wissert M, Primiani A, Hung C, et al. Antepartum treatment without early cordocentesis for standard-risk alloimmune thrombocytopenia: a randomized controlled trial. Obstet Gynecol. 2007;110(2 Pt 1):249-55.
15. Van den Akker E, Oepkes D, Lopriore E, Brand A, Kanhai H. Noninvasive antenatal management of fetal and neonatal alloimmune thrombocytopenia: safe and effective. BJOG. 2007;114(4):469-73.
16. Bussel JB, Berkowitz RL, Hung C, Kolb EA, Wissert M, Primiani A, et al. Intracranial hemorrhage in alloimmune thrombocytopenia: stratified management to prevent recurrence in the subsequent affected fetus. Am J Obstet Gynecol. 2010;203(2):135.e1-14.
17. Kaplan C, Murphy MF, Kroll H, Waters AH. Feto-maternal alloimmune thrombocytopenia: antenatal therapy with IvIgG and steroids-more questions than answers. European Working Group on FMAIT. Br J Haematol. 1998;100(1):62-5.
18. Sainio S, Teramo K, Kekomäki R. Prenatal treatment of severe fetomaternal alloimmune thrombocytopenia. Transfus Med. 1999;9(4): 321-30.
19. Giers G, Wenzel F, Stockschlader M, Riethmacher R, Lorenz H, Tutschek B. Fetal alloimmune thrombocytopenia and maternal intravenous immunoglobin infusions. Haematologica. 2010;95(11):1921-6.
20. Bussel JB, Skupski DW, McFarland JG. Fetal alloimmune thrombocytopenia: consensus and controversy. J Matern Fetal Med. 1996;5(5): 281-92.
21. Bussel JB, Zabusky MR, Berkowitz RL, McFarland JG. Fetal alloimmune thrombocytopenia. N Engl J Med. 1997;337(1):22-6.
22. Paidas MJ, Berkowitz RL, Lynch L, Lockwood CJ, Lapinski R, McFarland JG, et al. Alloimmune thrombocytopenia: fetal and neonatal losses related to cordocentesis. Am J Obstet Gynecol. 1995;172(2 Pt 1):475-9.
23. Radder CM, Brand A, Kanhai HH. A less invasive treatment strategy to prevent intracranial hemorrhage in fetal and neonatal alloimmune thrombocytopenia. Am J Obstet Gynecol. 2001;185(3):683-8.
24. Bowman JM, Pollock JM, Peterson LE, Harman CR, Manning FA, Menticoglou SM. Fetomaternal hemorrhage following funipuncture: increase in severity of maternal red-cell alloimmunization. Obstet Gynecol. 1994;84(5):839-43.
25. Vietor HE, Kanhai HHH, Brand A. Induction of additional red cell alloantibodies after intrauterine transfusions. Transfusion. 1994;34 (11):970-4.
26. Hohlfeld P, Forestier F, Kaplan C, Tissot JD, Daffos F. Fetal thrombocytopenia: a retrospective survey of 5,194 fetal blood samplings. Blood. 1994;84(6):1851-6.
27. Murphy MF, Metcalfe P, Waters AH, Ord J, Hambley H, Nicolaides K. Antenatal management of severe feto-maternal alloimmune thrombocytopenia: HLA incompatibility may affect responses to fetal platelet transfusions. Blood. 1993;81(8):2174-9.
28. Boehlen F, Kaplan C, de Moerloose P. Severe neonatal alloimmune thrombocytopenia due to anti-HPA-3a. Vox Sang. 1998;74(3):201-4.